Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Accelleron Industries shares rose in early European trading after the engine-turbocharger maker posted higher earnings for 2024 and said it exceeded $1 billion in revenue for the first time. Shares ...

Poland's PKO BP posted a 259% year-on-year rise in fourth-quarter net profit on Thursday, due to improving income from core ...

Accelleron Industries AG / Key word (s): Annual Results Accelleron breaks through the USD 1 billion revenue mark 13-March-2025 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR ...

In the competitive world of sports apparel, the Swiss brand On is making waves. Characterized by impressive growth, On is challenging industry norms typically dominated by giants like Adidas and Nike.

IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...

DocMorris shares plunged after it posted a full-year loss on higher marketing costs to boost its digital prescription sales in Germany. In European early morning trade, shares of DocMorris fell 21% to ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Investing.com -- Shares of DocMorris, the Switzerland-listed online pharmacy, saw a steep decline in early European trading, falling 21% to 16.60 Swiss francs.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

On Holding (NYSE:ONON) recently provided robust earnings guidance and announced a significant uptick in both quarterly and yearly sales figures, signaling financial strength and growth potential.

Additionally, the EUR/JPY cross faces pressure as the Euro (EUR) struggles amid dampened market sentiment following the European Union’s (EU) retaliatory tariffs on the United States (US). The US ...